Methimazole (Par Pharmaceutical)
Welcome to the PulseAid listing for the Methimazole drug offered from Par Pharmaceutical. This Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical |
| NON-PROPRIETARY NAME: | methimazole |
| SUBSTANCE NAME: | METHIMAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-02-28 |
| END MARKETING DATE: | 0000-00-00 |
Methimazole HUMAN PRESCRIPTION DRUG Details:
| Item Description | Methimazole from Par Pharmaceutical |
| LABELER NAME: | Par Pharmaceutical |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2012-02-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49884-640_02083e1f-eb8b-41af-8747-e32a5b551120 |
| PRODUCT NDC: | 49884-640 |
| APPLICATION NUMBER: | ANDA040350 |
Other METHIMAZOLE Pharmaceutical Manufacturers / Labelers:
